Back to Stakeholders
Independent Academic Research Groups

Jiangsu HengRui Medicine Co., Ltd.

China
1 Trial

Jiangsu HengRui Medicine Co., Ltd. is one of China's largest publicly listed pharmaceutical companies, specializing in innovative drugs across oncology, anesthesia, and metabolic diseases. The company has developed HR071603, a proprietary ketamine nasal spray candidate, which entered Phase I clinical evaluation in healthy subjects.

Quick Facts

Type
Public Biotech
HQ
China
Website
Visit

Sponsored Trials

1
CompletedI

A Study of HR071603 (Ketamine Nasal Spray) in Healthy Subjects

Start Date
Compounds
Ketamine, Placebo